More Business Wire
View Older Stories View Newer Stories-
AI Explainability Uncovers Surprising Truth About Jesse James in New Documentary
-
Strike Narrowly Averted as Unions Reach Settlement with Save Mart/Lucky/FoodMaxx
-
A Phase 3 Ready DMD Gene Therapy, a Clinical Trial to Offset AAV Neutralizing Antibodies, and an AI Inspired New Generation of Capsids Highlight Genethon’s 2024 Fall Milestones
-
Arverne Group Announces the Completion, by Its Subsidiary 2gré, of Its First 3D Subsurface Exploration Campaign in the Auvergne-Rhône-Alpes region
-
Rio Tinto appoints new Chief People Officer
-
Atlassian Appoints Christian Smith, Splunk’s Chief Revenue Officer at Cisco, to Board of Directors
-
Energy Dome and ENGIE Sign Pioneering Storage Offtake Agreement
-
Ukraine Conflict Impacting Nordics Cloud Adoption
-
GIVEMESPORT Signs World-Renowned Transfer Insider Fabrizio Romano to Join its Football Coverage
-
Groupe SEB: French Competition Authority Inquiry
-
New Skechers Concept Store Opens in Prague
-
Dong-A ST Secures European Approval for Stelara Biosimilar IMULDOSA
-
ASTRA 1P Starts Delivering Content Across Europe
-
Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
-
Palliser Capital Announces Submission of Resolution to Rio Tinto Calling for Independent Review on Unifying Dual Listing
-
Thales to Enhance Vehicle Access With Reliable and Secure Contactless Solutions
-
Rupert Resources Provides Ikkari Project Update
-
Kao Corporation: Regarding the Nomination of Director Candidates for Our Company
-
Micromax and Phison Partner to Launch MiPhi, Powering India’s Next-Generation of NAND Storage Technology
-
Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease
-
Genentech’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, but Suggests Possible Benefit in Early-Stage Parkinson’s Disease
-
Antin Infrastructure Partners Closes Flagship Fund V Above €10 Billion Target
-
Self-Care for the Skin: The Ultimate Holiday Gift by Quanta System
-
MBK Partners and Young Poong Expand Stake in Korea Zinc to 46.7% of Voting Shares
-
KKR Invests in Leading Internet Restaurant Company Rebel Foods
-
Saviynt University Empowers 250+ IAM Practitioners in India, Accelerating Time-to-Value for Partners
-
FDA Approval of Ensartinib for ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
-
Experience a Unique Hong Kong Chinese New Year
-
WM Technology Confirms Receipt of Non-Binding Proposal from Co-Founders Regarding Potential Take-Private
-
Marcus & Millichap’s Institutional Property Advisors Brokers $203 Million Sale and Arranges $127.8 Million Financing for Silicon Valley Multifamily Asset
-
Santander Bank Lowers Its Prime Rate to 7.50%
-
Momentus Announces Closing of $5 Million Offering Priced At-The-Market Under NASDAQ Rules
-
Strategic Storage Growth Trust III, Inc. Expands Portfolio With New Acquisition in Alberta, Canada
-
Asian Enterprises Snap Up Cloud Services as Economies Rise
-
VeriSilicon Unveils Next-Generation High-Performance Vitality Architecture GPU IP Series
-
Can You Go Home Again? New UC Davis Study Looks at the Workplace Effects of Boomerangs
-
Vesta Announces Closing of US$545 Million Global Syndicated Sustainable Credit Facility Including US$200 Million Revolving Credit Facility
-
HSBC Bank USA, N.A. and Affiliates Reduces Prime and Reference Rate
-
Woodside Simplifies Portfolio and Unlocks Long-Term Value
-
Webster Lowers Prime Lending Rate to 7.50 Percent
-
Air Canada Flight Attendants Are Launching an Interactive Pop-up Experience to Fight Back Against Unpaid Work
-
Deutsche Bank Decreases Prime Lending Rate to 7.50%
-
Northern Trust Decreases Prime Rate
-
U.S. Bank Decreases Prime Lending Rate to 7.50 Percent
-
KBRA Comments on Enterprise Bancorp, Inc.'s Proposed Merger Agreement with Independent Bank Corp.
-
WM Sets Date for Fourth Quarter and Full-Year 2024 Earnings Release Conference Call
-
Citizens Financial Group Announces Prime Rate Change
-
VictoriaMetrics helps IHI Terrasun win big in Vegas on $1.2B clean energy project
-
DOJ Files Complaint in Intervention in Baron & Budd Whistleblower Lawsuit Against CVS Pharmacy
-
Concerned Shareholder Group Calls for Atea Pharmaceuticals to Appoint a New, Shareholder-Oriented Lead Independent Director to Oversee Strategic Review Process
